These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21239386)

  • 1. TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.
    Lorenzen JM; David S; Richter A; de Groot K; Kielstein JT; Haller H; Thum T; Fliser D
    Nephrol Dial Transplant; 2011 Apr; 26(4):1421-4. PubMed ID: 21239386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation.
    Koc M; Toprak A; Arikan H; Odabasi Z; Elbir Y; Tulunay A; Asicioglu E; Eksioglu-Demiralp E; Glorieux G; Vanholder R; Akoglu E
    Nephrol Dial Transplant; 2011 Mar; 26(3):955-63. PubMed ID: 20729266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients.
    Kuroki Y; Tsuchida K; Go I; Aoyama M; Naganuma T; Takemoto Y; Nakatani T
    Int J Mol Med; 2007 May; 19(5):783-90. PubMed ID: 17390084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of toll-like receptor 4 expression on the surface of peripheral blood mononuclear cells in uremic patients].
    Wang ZS; Xu DM; Guan GJ; Cui MY; Wei Y; Tang LJ; Jia XY; Li WB
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(34):2389-91. PubMed ID: 21092506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte toll-like receptor expression in end-stage kidney disease.
    Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
    Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease.
    Rastmanesh MM; Bluyssen HA; Joles JA; Boer P; Willekes N; Braam B
    Eur J Pharmacol; 2008 Sep; 593(1-3):99-104. PubMed ID: 18656467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Katoh T; Miyata T; Watanabe T
    Nephrol Dial Transplant; 2011 Jan; 26(1):214-20. PubMed ID: 20591816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease.
    Ulrich C; Heine GH; Garcia P; Reichart B; Georg T; Krause M; Köhler H; Girndt M
    Nephrol Dial Transplant; 2006 Jun; 21(6):1596-602. PubMed ID: 16476718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
    Rogacev KS; Seiler S; Zawada AM; Reichart B; Herath E; Roth D; Ulrich C; Fliser D; Heine GH
    Eur Heart J; 2011 Jan; 32(1):84-92. PubMed ID: 20943670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic study of cardiac and renal events in Japanese patients with chronic kidney disease and cardiovascular risk using myocardial perfusion SPECT: J-ACCESS 3 study design.
    Nakamura S; Kawano Y; Hase H; Hatta T; Nishimura S; Moroi M; Nakagawa S; Kasai T; Kusuoka H; Takeishi Y; Nakajima K; Momose M; Takehana K; Nanasato M; Yoda S; Nishina H; Matsumoto N; Nishimura T
    Ther Apher Dial; 2010 Aug; 14(4):379-85. PubMed ID: 20649758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine as a modulator of the immune system of critical care patients: effect on Toll-like receptor expression. A preliminary study.
    Pérez-Bárcena J; Regueiro V; Marsé P; Raurich JM; Rodríguez A; Ibáñez J; de Lorenzo Mateos AG; Bengoechea JA
    Nutrition; 2008 Jun; 24(6):522-7. PubMed ID: 18367379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between kidney function and risk of asymptomatic peripheral arterial disease in elderly subjects.
    De Graauw J; Chonchol M; Poppert H; Etgen T; Sander D
    Nephrol Dial Transplant; 2011 Mar; 26(3):927-32. PubMed ID: 20670957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the impact of diabetes on mortality in chronic dialysis patients.
    Carrero JJ; de Mutsert R; Axelsson J; Dekkers OM; Jager KJ; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2011 Jan; 26(1):270-6. PubMed ID: 20621930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
    Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
    J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.